Epidemiology of HIV infection in the newborn

Early Human Development

Volumn 58, Issue 1, 2000, Pages 1-16

  Thorne, Claire ^a   Newell, Marie Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

HIV infection; Prevention; Vertical transmission

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BREAST FEEDING; CESAREAN SECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT FEEDING; INFECTION PREVENTION; NEWBORN; NEWBORN PERIOD; PASSIVE IMMUNIZATION; PREMATURITY; PROPHYLAXIS; REVIEW; VERTICAL TRANSMISSION;

EID: 0033998684     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(00)00049-9     Document Type: Article

References (113)

1. AIDS epidemic update: December 1998. 1999;UNAIDS, Geneva.
2. Cazein F., Hamers F.F., Brunet J.B. HIV prevalence in pregnant women in europe: differences in assessment methods and prevalence levels across countries. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:1998;296-305.
3. Davis S.F., Rosen D.H., Steinberg S., Wortley P.M., Karon J.M., Gwinn M. Trends in HIV prevalence among childbearing women in the United States, 1989-1994. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:1998;158-164.
4. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS. 10:1996;1675-1681.
5. Kumar R.M., Uduman S.A., Khurranna A.K. A prospective study of mother-to-infant HIV transmission in tribal women from India. J. AIDS. 9:1995;238-242.
6. Matheson P.B., Thomas P.A., Abrams E.J., Pliner V., Lambert G., Bamji M., et al. Heterosexual behaviour during pregnancy and perinatal transmission of HIV-1. AIDS. 10:1996;1249-1256.
7. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:1995;506-510.
8. Newell M.L. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS. 12:1998;831-837.
9. Rubini N.D.P.M., Passman L.J. Transmission of human immunodeficiency virus infection from a newly infected mother to her two-year old child by breastfeeding. Pediatr. Infect. Dis. J. 11:1992;682-683.
10. Van de Perre P., Hitimana D., Simonon A., Dabis F., Msellati P., Karita E., et al. Postnatal transmission of HIV-1 associated with breast abscess. Lancet. 339:1992;1490-1491.
11. Van de Perre P., Simonon A., Msellati P., Hitimana D.-G., Vaira D., Bazubagira A., et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant: a prospective cohort study in Kigali, Rwanda. N. Eng. J. Med. 325:1991;593-598.
12. Dunn D., Newell M.L., Ades A., Peckham C.S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 340:1992;585-588.
13. Bertolli J., St. Louis M.E., Simonds R.J., Nieburg P.I., Kamenga M., Brown C., et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breastfeeding population in Kinshasa, Zaire. J Infect Dis. 174:1996;722-726.
14. Simonon A., Lepage P., Karita E., Hitimana D.G., Dabis F., Msellati P., et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J. AIDS. 7:1994;952-957.
15. Leroy V., Newell M.L., Dabis F., Peckham C., Van de Perre P., Bulterys M., et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. The Lancet. 352:1998;597-600.
16. Newell M.L., Peckham C. Risk factors for vertical transmission of HIV-1 and early markers of HIV-1 infection in children. AIDS. 7:(Suppl 1):1993;S591-S597.
17. O'Shea S., Newell M.L., Dunn D., Garcia-Rodriguez M.C., Bates I., Mullen J., et al. Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J. Med. Virol. 54:1998;113-117.
18. Mock P., Shaffer N., Bhadrakom C., Siriwasin W., Chotpitayasunondh T., Chearskul S., et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. AIDS. 13:1999;407-414.
19. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS. 13:1999;1377-1385.
20. Garcia P., Kalish L.A., Pitt J., Minkoff H., Quinn T.C., Burchett S.K., et al. Maternal levels of plasma human immunodeficiency virus type-1 RNA and the risk of perinatal transmission. N. Eng. J. Med. 341:1999;394-402.
21. Mofenson L.M., Lambert J.S., Stiechm E.R., Bethel J., Meyer III W.A., Whitehouse J., et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N. Eng. J. Med. 341:1999;385-393.
22. Coll O., Hernandez M., Boucher C.A.B., Fortuny C., de Tejada B.M., Canet Y., et al. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:1997;26-30.
23. Mayaux M.J., Dussaix E., Isopet J., Rekacewicz C., Mandelbrot L., Ciraru-Vigneron N., et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohort studies. J. Infect. Dis. 175:1997;172-175.
24. Sperling R.S., Shapiro D.E., Coombs R.W., Todd J.A., Herman S.A., McSherry G.D., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N. Eng. J. Med. 335:1996;1621-1629.
25. Bulterys M., Landesman S., Burns D., Rubinstein A., Goedert J.J. Sexual behaviour and injecting drug use during pregnancy and vertical transmission of HIV-1. J. AIDS. 15:1997;76-82.
26. Rodriguez E.M., Mofenson L.M., Chang B.H., Rich K.C., Fowler M.G., Smeriglio V., et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 10:1996;273-282.
27. Greenberg B.L., Semba R.D., Vink P.E., Farley J.J., Sivapalsingam M., Steketee R.W., et al. Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS. 11:1997;325-332.
28. Semba R.D., Miotti P.G., Chiphangwi J.D., Saah A.J., Canner J.K., Dallabetta G.A., et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet. 343:1994;1593-1597.
29. Nduati R.W., John G.C., Richardson B.A., Overbaugh J., Welch M., Ndinya-Achola J., et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J. Infect. Dis. 172:1995;1461-1468.
30. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomised clinical trial. Lancet. 353:1999;1035-1039.
31. Ryder R.W., Nsa W., Hassig S.E., Behets F., Rayfield M., Ekungola B., et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N. Eng. J. Med. 320:1989;1637-1642.
32. Van Dyke R.B., Korber B.T., Popek E., Macken C., Widmayer A.B., Bardeguez A., et al. The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. J Infect Dis. 179:1999;319-328.
33. Landesman S.H., Kalish L.A., Burns D., Minkoff H., Fox H.E., Zorrilla C., et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother-to-child. N. Eng. J. Med. 334:1996;1617-1623.
34. Nair P., Alger L., Hines S., Seiden S., Hebel R., Johnson J.P. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J. AIDS. 6:1993;298-302.
35. Mandelbrot L., Le Chenadec J., Berrebi A., Bongain A., Benifla J.L., Delfraissy J.F., et al. Perinatal HIV-1 transmission-interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. J Am Med Assoc. 280:(1):1998;55-60.
36. Tovo P.-A., de Martino M., Gabiano C., Galli L., Cappello N., Ruga E., et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11:1996;88-94.
37. Mandelbrot L., Mayaux M.J., Bongain A., Berrebi A., Moudoub-Jeanpetit Y., Benifla J.L., et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts. Am. J. Obstet. Gynecol. 175:1996;661-667.
38. Kuhn L., Steketee R.W., Weedon J., Abrams E.J., Lambert G., Bamji M., et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. J. Infect. Dis. 179:1999;52-58.
39. Tess B.H., Rodrigues L.C., Newell M.L., Dunn D.T., Lago T.D.G. Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. AIDS. 12:1998;513-520.
40. John G., Ngacha D.A., Richardson B.A., Mwatha A., Overbaugh J., Bwayo J.J., et al. Correlates of perinatal HIV-1 transmission in the Kenyan Breastfeeding Study. XI International Conference on AIDS and STDs in Africa, 12-16th September 1999, Lusaka, Zambia :1999;. Abstracts book:13ET5-1.
41. Embree J.E., Njenga S., Datta P., Nagelkerke N., Ndinya-Achola J., Mohammed Z., et al. Risk factors for postnatal mother-to-child transmission of HIV-1. The Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, September 1-6, 1999, Montreal, Canada :1999;. Abstracts:201.
42. Semba R.D., Kumwenda N.I., Hoover D.R., Taha T.E., Quinn T.C., Mtimavalye L., et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis. 180:1999;93-98.
43. Coutsoudis A., Pillay K., Spooner E., Kuhn L., Coovadia H. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. Lancet. 354:1999;471-476.
44. Brocklehurst P., French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta analysis. Br. J. Obstet. Gynaecol. 105:1998;836-848.
45. Is zidovudine therapy in pregnant hiv-infected women associated with gestational age and birthweight. AIDS. 13:(1):1999;119-124.
46. Martin R., Boyer P., Hammill H., Peavy H., Platzker A., Settlage R., et al. Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. J. Pediatr. 131:1997;851-856.
47. Marion R.W., Wiznia A.A., Hutcheon R.G., Rubinstein A. Human T-Cell lymphotropic virus type III (HTLV-III) embryopathy. Am. J. Dis. Child. 140:1986;638-640.
48. Perinatal findings in children born to HIV-infected mothers. Br. J. Obstet. Gynaecol. 101:1994;136-141.
49. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb Mortal Wkly Rep. 43:(RR12):1994;1-10.
50. Dunn D., Brandt C.D., Krivine A., Cassol S.A., Roques P., Borkowsky W., et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 9:1995;F7-F11.
51. Morbidity and mortality in European children vertically infected by HIV-1. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:1997;442-450.
52. Mayaux M., Burgard M., Teglas J., Cottalorda J., Krivine A., Simon F., et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. J Am Med Assoc. 275:1996;606-610.
53. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics. 94:1994;815-819.
54. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet. 343:1994;191-195.
55. Pizzo P.A., Wilfert C.M. Pediatric Aids Siena Workshop. Markers and determinants of disease progression in children with HIV infection. J. AIDS. 8:1995;30-44.
56. Shearer W., Quinn T.C., LaRussa P., Lew J.F., Mofenson L., Almy S., et al. Viral load and disease progression in infants infected with human immunodeficiency virus type I. N. Eng. J. Med. 336:1997;1337-1342.
57. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. AIDS. 12:1998;F1-F8.
58. Galli L., de Martino M., Tovo P.-A., Gabiano C., Zappa M., Giaquinto C., et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS. 9:1995;455-461.
59. Frederick T., Mascola L., Eller A., O'Neill L., Byers B. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Pediatr. Infect. Dis. J. 13:1994;1091-1097.
60. Scott G.B., Hutto C. Prognosis in pediatric HIV infection. Pizzo P.A., Wilfert C.M. Pediatric AIDS. The challenge of HIV infection in infants, children and adolescents. 1991;187-198 Williams and Wilkins, Baltimore.
61. Blanche S., Tardieu M., Duliege A.M., Rouzioux C., Le Deist F., Fukunaga K., et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am. J. Dis. Child. 144:1990;1210-1215.
62. Tovo P.A., De Martino M., Gabiano C., Cappello N., D'Elia R., Loy A., et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet. 339:1992;1249-1253.
63. Bamji M., Thea D.M., Weedon J., Krasinski K., Matheson P.B., Thomas P., et al. Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. Pediatr. Infect. Dis. J. 15:1996;891-898.
64. Kind C., Brandle B., Wyler C.A., Calame A., Rudin C., Schaad U.B., et al. Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur. J. Pediatr. 151:1992;442-448.
65. Risk factors for mother-to-child transmission of HIV-1. Lancet. 339:1992;1007-1012.
66. Mayaux M.J., Teglas J.P., Mandelbrot L., Berrebi A., Gallais H., Matheron S., et al. Acceptability and impact of zidovudine prevention on mother-to-child HIV-1 transmission in France. J. Pediatr. 131:1997;857-862.
67. Kind C., Rudin C., Siegrist C.-A., Wyler C.A., Biedermann K., Lauper U., et al. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. AIDS. 12:1998;205-210.
68. Cooper E.R., Nugent R.P., Pitt J., Hanson C., Kalish L.A., Mendez H., et al. After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J. Infect. Dis. 174:1996;1207-1211.
69. Fiscus S.A., Adimora A.A., Schoenbach V.J., Lim W., McKinney R., Rupar D., et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. J Am Med Assoc. 275:1996;1483-1488.
70. Wade N.A., Birkhead G.S., Warren B.L., Charbonneau T.T., French T., Wang L., et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N. Eng. J. Med. 339:1998;1409-1414.
71. HIV and infant feeding. Guidelines for decision makers. 1998;UNAIDS, Geneva.
72. Miotti P.G., Taha T.E., Kumwenda N.I., Broadhead R., Mtimavalye L., Van den Hoeven L., et al. HIV transmission through breastfeeding. A study in Malawi. J Am Med Assoc. 282:1999;744-749.
73. Tess B.H., Rodrigues L.C., Newell M.L., Dunn D., Lago T.D.G. Infant Feeding and Risk of Mother-to-Child Transmission of HIV-1 in Sao Paulo State, Brazil. J. AIDS. 19:(2):1998;189-194.
74. Bobat R., Moodley D., Coutsoudis A., Coovadia H. Breastfeeding by HIV-1 infected women and outcome in their infants: a cohort study from Durban, South Africa. AIDS. 11:1997;1627-1633.
75. Nduati R., John G., Ngacha D.A., Richardson S., Overbaugh J., Mwatha A., et al. Breastfeeding transmission of HIV-1: a randomised clinical trial. XI International Conference on AIDS and STDs in Africa, 12-16th September 1999, Lusaka, Zambia :1999;. Abstracts book:13ET5-2.
76. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet. 343:1994;1464-1467.
77. Duliege A.M., Amos C.I., Felton S., Biggar R.J., Goedert J.J. The International Registry of HIV-exposed Twins. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J. Pediatr. 126:1995;625-632.
78. Dunn D., Newell M.L., Mayaux M.J., Kind C., Hutto C., Goedert J., et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J. AIDS. 7:1994;1064-1066.
79. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies. N. Engl. J. Med. 340:(13):1999;977-987. Abstract.
80. Tovo P.-A., Newell M.L., Mandelbrot L., Semprini A., Giaquinto C. Recommendations for the management of HIV infected women and their infants - A European Consensus. 1999;European Commission, Luxembourg.
81. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. ACOG Committee Opinion. 219:1999;1-3.
82. Burger H., Kovacs A., Weiser B., Grimson R., Nachman S., Tropper P., et al. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:1997;321-326.
83. Coutsoudis A., Pillay K., Spooner E., Kuhn L., Coovadia H. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS. 13:1999;1517-1524.
84. Stiehm E.R., Lambert J.S., Mofenson L.M., Bethel J., Whitehouse J., Nugent R., et al. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women and advanced disease: results of Pediatric AIDS Clinical Trials Group Protocol 185. J. Infect. Dis. 179:1999;567-575.
85. Shaffer N., Chuachoowong R., Mock P.A., Bhadrakom C., Siriwasin W., Young N.L., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 353:1999;773-780.
86. Henin Y., Mandelbrot L., Henrion R., Pradineaud R., Montagnier L. HIV in the cervicovaginal secretions of pregnant and non-pregnant women. J. AIDS. 6:1993;72-75.
87. Clemetson D.B.A., Moss G.B., Willerford D.M., Hensel M., Emonyi W., Holmes K.K., et al. Detection of HIV DNA in cervical and vaginal secretions. J Am Med Assoc. 269:1993;2860-2864.
88. Hart C.E., Lennox J.L., Pratt-Palmore M., Wright T.C., Schinazi R.F., Evans-Strickfaden T., et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J. Infect. Dis. 179:1999;871-872.
89. Biggar R.J., Miotti P.G., Taha T.E., Mtimavalye L., Broadhead R., Justesen A., et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 347:1996;1647-1650.
90. Taha T.E., Biggar R.J., Broadhead R.L., Mtimavalye L.A.R., Justesen A., Liomba G.N., et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. Br Med J. 315:1997;216-220.
91. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Eng. J. Med. 331:1994;1173-1180.
92. Dabis F., Msellati P., Meda N., Welffens-Ekra C., You B., Manigart O., et al. Six month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo controlled multicentre trial. Lancet. 353:1999;786-792.
93. Wiktor S.Z., Ekpini E., Karon J.M., Nkenganson J., Maurice C., Severin S.T., et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet. 353:1999;781-785.
94. de Jong M.D., de Boer R.J., de Wolf F., Foudraine N.A., Boucher C.A.B., Goudsmit J., et al. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. AIDS. 11:1997;F79-F84.
95. Wiktor S.Z., Ekpini E., Sibailly T.S., Diaby L., Brown T., Fransen K., et al. The effectiveness of oral zidovudine administered in late pregnancy in lowering plasma and cervicovaginal hiv-1 viral load in hiv-infected pregnant women in abidjan, cote d'ivoire. XI International Conference on AIDS, Vancouver :1996;. Abstracts1:TuC443.
96. Guay L., Musoke P., Fleming T., Bagenda D., Allen M., Nakabiito C., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354:1999;795-802.
97. Marseille E., Kahn J.G., Mmiro F., Guay L., Musoke P., Fowler M.G., et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 354:1999;803-809.
98. Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br. J. Obstet. Gynaecol. 105:1998;704-709.
99. Kirk O., Mocroft A., Katzenstein T.L., Lazzarin A., Antunes F., Francioli P., et al. Changes in use of antiretroviral therapy in regions of Europe over time. AIDS. 12:(15):1998;2031-2039.
100. Spira R., Marimoutou C., Binquet C., Lacoste D., Dabis F. Rapid change in use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995 to 1997. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:1998;358-364.
101. Saba J. The PETRA Study. A multicentre, randomised double placebo-controlled clinical trial to evaluate the efficacy, tolerance and effectiveness of 3 drug regimens using zidovudine and lamivudine for the prevention of mother-to-child transmission of HIV-1. Sixth Conference on Retroviruses and Opportunistic Infections, 31 Jan-4 Feb 1999, Chicago, USA :1999;. Abstracts.
102. Lorenzi P., Spicher V.M., Laubereau B., Hirschel B., Kind C., Rudin C., et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS. 12:1998;F241-F247.
103. Taylor G.P., Lyall E.G.H., Mercey D., Smith J.R., Chester T., Newell M.L., et al. British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sexual Transmit Infect. 75:1999;90-97.
104. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. Morb Mortal Wkly Rep. 43:(RR-11):1994;1-20.
105. Sperling R.S., Shapiro D.E., McSherry G.D., Britto P., Cunningham B.E., Culnane M., et al. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 study. AIDS. 12:1998;1805-1813.
106. Watson W.J., Stevens T.P., Weinberg G.A. Profound anaemia in a newborn infant of a mother receiving antiretroviral therapy [letter]. Paediatr. Infect. Dis. J. 17:1999;435-436.
107. Toltzis P., Marz C.M., Kleinman N., Levine E.M., Schmidt E.V. Zidovudine-associated embryonic toxicity in mice. J. Infect. Dis. 163:1991;1212-1218.
108. Olivero O.A., Shearer G.M., Chougnet C.A., Kovacs A.A.S., Landay A.L., Baker R., et al. Incorporation of zidovudine into leukocyte DNA from HIV-1 positive adults and pregnant women and cord blood from infants exposed in utero. AIDS. 13:1999;919-925.
109. Culnane M., Fowler M.G., Lee S.S., McSherry G., Brady M., O'Donnell K., et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. J. Am Med Assoc. 13:(2):1999;151-157.
110. Scalfero P., Chesaux J.J., Buchwalder P.A., Biollaz J., Micheli J.L. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Med. 24:1998;247-250.
111. Russo F., Collantes C., Guerrero J. Severe paronychia due to zidovudine induced neutropenia in a neonate. J Am Acad Dermatol. 40:(Suppl II):1999;322-324.
112. Blanche S., Tardieu M., Rustin P., Stama A., Barret B., Firtion G., et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 354:1999;1084-1089.
113. Diaby L., Sibailly T.S., Ekpini E.R., Nkenganson J., et al. Effectiveness of a short- course oral zidovudine regimen in preventing mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: long-term follow-up in a breastfeeding population. XI International Conference on AIDS and STDs in Africa, 12-16th September 1999, Lusaka, Zambia :1999;. Abstracts:15PT38-90.